Finance
UBS Group is at the center of a proposed adjustment to Switzerland’s regulatory capital framework that could give the bank greater flexibility in how it capitalizes its foreign subsidiaries. The parliamentary committee proposal would allow part of those requirements to be satisfied through Additional Tier 1 (AT1) instruments rather than relying entirely on Common Equity Tier 1 capital.
The proposal addresses a particularly important issue for UBS because of the bank’s extensive international footprint. Capital requirements imposed on foreign subsidiaries can tie up substantial amounts of high-quality equity capital, limiting the resources available for other parts of the group.
Allowing AT1 instruments to satisfy part of those requirements could therefore change how UBS allocates capital between its Swiss parent and overseas businesses. Rather than maintaining the entire buffer in the highest-quality CET1 form, the bank could potentially use a broader mix of regulatory capital instruments while continuing to meet applicable requirements.
The timing is significant. UBS continues to operate under heightened regulatory scrutiny following its acquisition and integration of Credit Suisse, while authorities remain focused on ensuring that the enlarged institution has sufficient resources to withstand stress.
For UBS, the central challenge is therefore not simply maximizing capital efficiency. It is finding a structure that preserves balance-sheet resilience while avoiding unnecessary constraints on the deployment of capital. Greater flexibility in subsidiary capitalization could help address that tension if the proposal ultimately receives parliamentary approval.
Additional flexibility could have implications beyond regulatory ratios. Capital that is not required to remain exclusively in CET1 form could potentially provide UBS with more room to support investments in its international operations, technology, integration initiatives and other strategic priorities.
The potential benefit should nevertheless be viewed as incremental rather than transformational. The proposal does not remove UBS’s capital obligations; it would alter the composition of capital available to satisfy certain requirements. The bank would still need to operate within broader Swiss and international regulatory expectations.
The most important point is that the proposal could improve UBS’s capital allocation flexibility without directly changing the bank’s underlying business model. For a global institution of UBS’s scale, that flexibility can matter materially because regulatory capital requirements influence the balance between growth, resilience and shareholder distributions.
However, the measure remains subject to the political and regulatory process. Until the proposal receives broader approval and its final provisions are established, investors should treat any potential benefit as prospective rather than certain. The key issue for UBS will be whether greater flexibility can coexist with regulators’ demand for robust loss-absorbing capacity.
For sophisticated global investors, the development reinforces the importance of monitoring not only UBS’s earnings and capital ratios, but also how Switzerland’s evolving regulatory framework shapes the bank’s capacity to deploy capital across jurisdictions.
For a confidential discussion regarding your cross-border banking structure and the strategic implications of evolving Swiss capital requirements, contact our senior advisory team.
September 3, 2026
September 3, 2026
September 3, 2026
September 3, 2026